β¨ Medicines Consent Notices
NEW ZEALAND GAZETTE
28 NOVEMBER
Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any)
--- | --- | --- | ---
Clarithromycin 500 mg | Tablet | Abbott Australasia Pty Limited, Kurnell, New South Wales, Australia; Abbott Laboratories Limited, Queenborough, Kent, England and Abbott SpA., Campoverde di Aprilia, Latina, Italy | Maclar
Flurbiprofen sodium 0.3 mg/mL in 0.4 mL | Eye drops | Allergan Pharmaceuticals (Ireland) Limited, Westport, County Mayo, Ireland | Ocufen Unit Dose Eye Drops
Vincristine sulphate 1 mg/1 mL, 2 mg/2 mL | Injection, pre-filled syringe | Eli Lilly International Corporation, Indianapolis, Indiana, United States of America and Lilly France S.A., Fegersheim, France | Oncovin Solution
Fluoxetine 20 mg | Tablet, dispersible | Eli Lilly & Company, Basingstoke, Hants, England; Eli Lilly International Corporation, Indianapolis, Indiana, United States of America and Lilly Espana S.A., Alcobendas, Madrid, Spain | Prozac 20
Dated this 22nd day of November 1996.
KAREN O. POUTASI (DR), Director-General of Health, pursuant to delegation given by the Minister of Health on the 18th day of January 1996.
g07705
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any)
--- | --- | --- | ---
Dicloxacillin sodium, anhydrous 559 mg, 1.117 g, 2.235 g equivalent to 500 mg, 1 g, 2 g dicloxacillin respectively | Powder for injection, vial | Bristol-Myers Squibb SpA., Sermoneta, Latina, Italy | Diclocil
Dicloxacillin sodium, anhydrous equivalent to 62.5 mg/5 mL, 125 mg/5 mL dicloxacillin in 100 mL | Powder for oral suspension | Bristol-Myers Squibb SpA., Sermoneta, Latina, Italy | Diclocil
Dicloxacillin sodium, anhydrous 275 mg, 551 mg, equivalent to 250 mg, 500 mg dicloxacillin respectively | Capsules | Bristol-Myers Squibb SpA., Sermoneta, Latina, Italy | Diclocil
Tamoxifen citrate 10 mg, 20 mg | Tablets | Egis Pharmaceuticals, Budapest, Hungary | Estroxin
Insulin lispro (rDNA origin) 100 U/mL in 10 mL | Injection, vial | Lilly France S.A., Fegersheim, France | Humalog
Insulin lispro (rDNA origin) 100 U/mL in 1.5 mL | Injection, cartridge | Lilly France S.A., Fegersheim, France | Humalog
Each 0.5 mL dose contains 8 mcg formalin treated 69 kDa outer membrane protein of B. pertussis, NLT 30 IU adsorbed diphtheria toxoid, 25 mcg formalin treated filamentous haemagglutinin, 25 mcg detoxified pertussis toxin, and NLT 40 IU adsorbed tetanus toxoid | Vaccine, prefilled syringe | Sachsisches Serumwerk GmbH., Dresden, Germany and SmithKline Beecham Biologicals, Rixensart, Belgium | Infanrix
Each 0.5 mL dose contains 8 mcg formalin treated 69 kDa outer membrane protein of B. pertussis, NLT 30 IU adsorbed diphtheria toxoid, 25 mcg formalin treated filamentous haemagglutinin, 25 mcg detoxified pertussis toxin, and NLT 40 IU adsorbed tetanus toxoid | Vaccine, vial | Sachsisches Serumwerk GmbH., Dresden, Germany and SmithKline Beecham Biologicals, Rixensart, Belgium | Infanrix
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1996, No 171
NZLII —
NZ Gazette 1996, No 171
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of Changed Medicines
(continued from previous page)
π₯ Health & Social Welfare22 November 1996
Medicines Act 1981, Medicines, Distribution, Clarithromycin, Flurbiprofen sodium, Vincristine sulphate, Fluoxetine
- KAREN O. POUTASI (DR), Director-General of Health
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social WelfareMedicines Act 1981, New Medicines, Distribution, Dicloxacillin sodium, Tamoxifen citrate, Insulin lispro, Vaccine